The Regents of The University of Colorado; A Body Corporate
发明人:
Kathrin M. Bernt,Tobias Neff
申请号：
US15327341
公开号：
US20170166976A1
申请日:
2015.07.17
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present disclosure relates to methods of treating AML associated with elevated levels of MN1 and HOXA9 expression by administering one or more DOT1L inhibitors and pharmaceutical compositions to subjects in need thereof.
